In today’s recent session, 1.38 million shares of the Hoth Therapeutics Inc (NASDAQ:HOTH) have been traded, and its beta is 0.79. Most recently the company’s share price was $1.39, and it changed around -$0.11 or -7.33% from the last close, which brings the market valuation of the company to $9.60M. HOTH at last check was trading at a discount to its 52-week high of $3.80, offering almost -173.38% off that amount. The share price’s 52-week low was $0.58, which indicates that the recent value has risen by an impressive 58.27% since then. We note from Hoth Therapeutics Inc’s average daily trading volume that its 10-day average is 50.16 million shares, with the 3-month average coming to 8.98 million.
Hoth Therapeutics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended HOTH as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. Hoth Therapeutics Inc is expected to report earnings per share of -0.26 for the current quarter.
Hoth Therapeutics Inc (NASDAQ:HOTH) trade information
Instantly HOTH has been showing red trend so far today with a performance of -7.33% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 1.9000 on recent trading dayincreased the stock’s daily price by 26.84%. The company’s shares are currently up 85.80% year-to-date, but still down -26.46% over the last five days. On the other hand, Hoth Therapeutics Inc (NASDAQ:HOTH) is 69.53% up in the 30-day period. We can see from the shorts that 0.63 million shares have been sold at a short interest cover period of 1.16 day(s).
Hoth Therapeutics Inc (HOTH) estimates and forecasts
Hoth Therapeutics Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 69.06 percent over the past six months and at a 48.70% annual growth rate that is well above the industry average of 16.50%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 15.18%.
HOTH Dividends
Hoth Therapeutics Inc’s next quarterly earnings report is expected to be released in February.
Hoth Therapeutics Inc (NASDAQ:HOTH)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.92% of Hoth Therapeutics Inc shares, and 5.31% of them are in the hands of institutional investors. The stock currently has a share float of 5.36%.
Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund were the top two Mutual Funds as of Sep 30, 2024 . The former held 38.8 shares worth $54325.0, making up 0.56% of all outstanding shares. On the other hand, Fidelity Extended Market Index Fund held roughly 35.83 shares worth around $50167.0, which represents about 0.52% of the total shares outstanding.
